Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 178 of 178 entries
Sorted by: Best Match Show Resources per page
Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma.

American journal of ophthalmology case reports

Mishra KK, Scholey JE, Daftari IK, Afshar A, Tsai T, Park S, Quivey JM, Char DH.
PMID: 32760850
Am J Ophthalmol Case Rep. 2020 Jun 22;19:100787. doi: 10.1016/j.ajoc.2020.100787. eCollection 2020 Sep.

PURPOSE: To describe the first series of six young uveal melanoma (UM) patients with oral isotretinoin and/or topical retinoid therapy prior to diagnosis.OBSERVATIONS: The case series is based on clinical observations at our UM quaternary referral center. Six UM...

Cite
Mishra KK, Scholey JE, Daftari IK, et al. Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma. Am J Ophthalmol Case Rep. 2020;19:100787doi: 10.1016/j.ajoc.2020.100787.
Mishra, K. K., Scholey, J. E., Daftari, I. K., Afshar, A., Tsai, T., Park, S., Quivey, J. M., & Char, D. H. (2020). Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma. American journal of ophthalmology case reports, 19100787. https://doi.org/10.1016/j.ajoc.2020.100787
Mishra, Kavita K, et al. "Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma." American journal of ophthalmology case reports vol. 19 (2020): 100787. doi: https://doi.org/10.1016/j.ajoc.2020.100787
Mishra KK, Scholey JE, Daftari IK, Afshar A, Tsai T, Park S, Quivey JM, Char DH. Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma. Am J Ophthalmol Case Rep. 2020 Jun 22;19:100787. doi: 10.1016/j.ajoc.2020.100787. eCollection 2020 Sep. PMID: 32760850; PMCID: PMC7390773.
Copy Download .nbib Format: NLM
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia.

Frontiers in oncology

Ueda M, Stefan T, Stetson L, Ignatz-Hoover JJ, Tomlinson B, Creger RJ, Cooper B, Lazarus HM, de Lima M, Wald DN, Caimi PF.
PMID: 32211336
Front Oncol. 2020 Mar 10;10:327. doi: 10.3389/fonc.2020.00327. eCollection 2020.

Glycogen synthase kinase-3 (GSK3) inhibitors induce differentiation and growth inhibition of acute myeloid leukemia (AML) cells. Our pre-clinical studies showed GSK3 inhibition leads to sensitization of AML cells to tretinoin-mediated differentiation. We conducted a phase I trial of lithium,...

Cite
Ueda M, Stefan T, Stetson L, et al. Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia. Front Oncol. 2020;10:327doi: 10.3389/fonc.2020.00327.
Ueda, M., Stefan, T., Stetson, L., Ignatz-Hoover, J. J., Tomlinson, B., Creger, R. J., Cooper, B., Lazarus, H. M., de Lima, M., Wald, D. N., & Caimi, P. F. (2020). Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia. Frontiers in oncology, 10327. https://doi.org/10.3389/fonc.2020.00327
Ueda, Masumi, et al. "Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia." Frontiers in oncology vol. 10 (2020): 327. doi: https://doi.org/10.3389/fonc.2020.00327
Ueda M, Stefan T, Stetson L, Ignatz-Hoover JJ, Tomlinson B, Creger RJ, Cooper B, Lazarus HM, de Lima M, Wald DN, Caimi PF. Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia. Front Oncol. 2020 Mar 10;10:327. doi: 10.3389/fonc.2020.00327. eCollection 2020. PMID: 32211336; PMCID: PMC7076174.
Copy Download .nbib Format: NLM
A Fiber Alginate Co-culture Platform for the Differentiation of mESC and Modeling of the Neural Tube.

Frontiers in neuroscience

Fannon OM, Bithell A, Whalley BJ, Delivopoulos E.
PMID: 33510605
Front Neurosci. 2021 Jan 12;14:524346. doi: 10.3389/fnins.2020.524346. eCollection 2020.

Alginate hydrogels are a commonly used substrate for

Cite
Fannon OM, Bithell A, Whalley BJ, et al. A Fiber Alginate Co-culture Platform for the Differentiation of mESC and Modeling of the Neural Tube. Front Neurosci. 2021;14:524346doi: 10.3389/fnins.2020.524346.
Fannon, O. M., Bithell, A., Whalley, B. J., & Delivopoulos, E. (2020). A Fiber Alginate Co-culture Platform for the Differentiation of mESC and Modeling of the Neural Tube. Frontiers in neuroscience, 14524346. https://doi.org/10.3389/fnins.2020.524346
Fannon, Orla M, et al. "A Fiber Alginate Co-culture Platform for the Differentiation of mESC and Modeling of the Neural Tube." Frontiers in neuroscience vol. 14 (2020): 524346. doi: https://doi.org/10.3389/fnins.2020.524346
Fannon OM, Bithell A, Whalley BJ, Delivopoulos E. A Fiber Alginate Co-culture Platform for the Differentiation of mESC and Modeling of the Neural Tube. Front Neurosci. 2021 Jan 12;14:524346. doi: 10.3389/fnins.2020.524346. eCollection 2020. PMID: 33510605; PMCID: PMC7835723.
Copy Download .nbib Format: NLM
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis.

Scientific reports

Farber M, Chen Y, Arnold L, Möllmann M, Boog-Whiteside E, Lin YA, Reinhardt HC, Dührsen U, Hanoun M.
PMID: 34764342
Sci Rep. 2021 Nov 11;11(1):22062. doi: 10.1038/s41598-021-01300-8.

Targeting the interaction between leukemic cells and the microenvironment is an appealing approach to enhance the therapeutic efficacy in acute myeloid leukemia (AML). AML infiltration induces a significant release of inflammatory cytokines in the human bone marrow niche which...

Cite
Farber M, Chen Y, Arnold L, et al. Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis. Sci Rep. 2021;11(1):22062doi: 10.1038/s41598-021-01300-8.
Farber, M., Chen, Y., Arnold, L., Möllmann, M., Boog-Whiteside, E., Lin, Y. A., Reinhardt, H. C., Dührsen, U., & Hanoun, M. (2021). Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis. Scientific reports, 11(1), 22062. https://doi.org/10.1038/s41598-021-01300-8
Farber, Meike, et al. "Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis." Scientific reports vol. 11,1 (2021): 22062. doi: https://doi.org/10.1038/s41598-021-01300-8
Farber M, Chen Y, Arnold L, Möllmann M, Boog-Whiteside E, Lin YA, Reinhardt HC, Dührsen U, Hanoun M. Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis. Sci Rep. 2021 Nov 11;11(1):22062. doi: 10.1038/s41598-021-01300-8. PMID: 34764342; PMCID: PMC8586007.
Copy Download .nbib Format: NLM
Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review.

The Journal of clinical and aesthetic dermatology

Spierings NMK.
PMID: 34980969
J Clin Aesthet Dermatol. 2021 Sep;14(9):33-40.

BACKGROUND: Skincare retailers sell a plethora of retinol-containing products, ranging from serums and moisturisers to masks and eye creams.OBJECTIVE: The purpose of this review is to critically appraise the randomized, double-blind, vehicle-controlled trials of the use of over-the-counter retinol...

Cite
Spierings NMK. Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review. J Clin Aesthet Dermatol. 2021;14(9):33-40
Spierings, N. M. K. (2021). Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review. The Journal of clinical and aesthetic dermatology, 14(9), 33-40.
Spierings, Natalia M K. "Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review." The Journal of clinical and aesthetic dermatology vol. 14,9 (2021): 33-40.
Spierings NMK. Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review. J Clin Aesthet Dermatol. 2021 Sep;14(9):33-40. PMID: 34980969; PMCID: PMC8675340.
Copy Download .nbib Format: NLM
Enhanced Synergistic-Antioxidant Activity of Melatonin and Tretinoin by Co-encapsulation into Amphiphilic Chitosan Nanocarriers: During Mice In Vitro Matured Oocyte/Morula-Compact Stage Embryo Culture Model.

Reproductive sciences (Thousand Oaks, Calif.)

Aghaz F, Vaisi-Raygani A, Khazaei M, Arkan E, Kashanian S.
PMID: 34231166
Reprod Sci. 2021 Dec;28(12):3361-3379. doi: 10.1007/s43032-021-00670-8. Epub 2021 Jul 06.

The use of exogenous antioxidants or the combination of them during in vitro oocyte/embryo culture media is reasonable. Co-delivery by nanocarrier has been designed to overcome the limitations of combining them traditionally. In this work, amphiphilic chitosan nanocarrier (ACN)...

Cite
Aghaz F, Vaisi-Raygani A, Khazaei M, et al. Enhanced Synergistic-Antioxidant Activity of Melatonin and Tretinoin by Co-encapsulation into Amphiphilic Chitosan Nanocarriers: During Mice In Vitro Matured Oocyte/Morula-Compact Stage Embryo Culture Model. Reprod Sci. 2021;28(12):3361-3379doi: 10.1007/s43032-021-00670-8.
Aghaz, F., Vaisi-Raygani, A., Khazaei, M., Arkan, E., & Kashanian, S. (2021). Enhanced Synergistic-Antioxidant Activity of Melatonin and Tretinoin by Co-encapsulation into Amphiphilic Chitosan Nanocarriers: During Mice In Vitro Matured Oocyte/Morula-Compact Stage Embryo Culture Model. Reproductive sciences (Thousand Oaks, Calif.), 28(12), 3361-3379. https://doi.org/10.1007/s43032-021-00670-8
Aghaz, Faranak, et al. "Enhanced Synergistic-Antioxidant Activity of Melatonin and Tretinoin by Co-encapsulation into Amphiphilic Chitosan Nanocarriers: During Mice In Vitro Matured Oocyte/Morula-Compact Stage Embryo Culture Model." Reproductive sciences (Thousand Oaks, Calif.) vol. 28,12 (2021): 3361-3379. doi: https://doi.org/10.1007/s43032-021-00670-8
Aghaz F, Vaisi-Raygani A, Khazaei M, Arkan E, Kashanian S. Enhanced Synergistic-Antioxidant Activity of Melatonin and Tretinoin by Co-encapsulation into Amphiphilic Chitosan Nanocarriers: During Mice In Vitro Matured Oocyte/Morula-Compact Stage Embryo Culture Model. Reprod Sci. 2021 Dec;28(12):3361-3379. doi: 10.1007/s43032-021-00670-8. Epub 2021 Jul 06. PMID: 34231166.
Copy Download .nbib Format: NLM
Youthful and age-related matreotypes predict drugs promoting longevity.

Aging cell

Statzer C, Jongsma E, Liu SX, Dakhovnik A, Wandrey F, Mozharovskyi P, Zülli F, Ewald CY.
PMID: 34346557
Aging Cell. 2021 Sep;20(9):e13441. doi: 10.1111/acel.13441. Epub 2021 Aug 04.

The identification and validation of drugs that promote health during aging ("geroprotectors") are key to the retardation or prevention of chronic age-related diseases. Here, we found that most of the established pro-longevity compounds shown to extend lifespan in model...

Cite
Statzer C, Jongsma E, Liu SX, et al. Youthful and age-related matreotypes predict drugs promoting longevity. Aging Cell. 2021;20(9):e13441doi: 10.1111/acel.13441.
Statzer, C., Jongsma, E., Liu, S. X., Dakhovnik, A., Wandrey, F., Mozharovskyi, P., Zülli, F., & Ewald, C. Y. (2021). Youthful and age-related matreotypes predict drugs promoting longevity. Aging cell, 20(9), e13441. https://doi.org/10.1111/acel.13441
Statzer, Cyril, et al. "Youthful and age-related matreotypes predict drugs promoting longevity." Aging cell vol. 20,9 (2021): e13441. doi: https://doi.org/10.1111/acel.13441
Statzer C, Jongsma E, Liu SX, Dakhovnik A, Wandrey F, Mozharovskyi P, Zülli F, Ewald CY. Youthful and age-related matreotypes predict drugs promoting longevity. Aging Cell. 2021 Sep;20(9):e13441. doi: 10.1111/acel.13441. Epub 2021 Aug 04. PMID: 34346557; PMCID: PMC8441316.
Copy Download .nbib Format: NLM
Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review.

The Journal of clinical and aesthetic dermatology

Spierings NMK.
PMID: 34980969
J Clin Aesthet Dermatol. 2021 Sep;14(9):33-40.

BACKGROUND: Skincare retailers sell a plethora of retinol-containing products, ranging from serums and moisturisers to masks and eye creams.OBJECTIVE: The purpose of this review is to critically appraise the randomized, double-blind, vehicle-controlled trials of the use of over-the-counter retinol...

Cite
Spierings NMK. Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review. J Clin Aesthet Dermatol. 2021;14(9):33-40
Spierings, N. M. K. (2021). Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review. The Journal of clinical and aesthetic dermatology, 14(9), 33-40.
Spierings, Natalia M K. "Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review." The Journal of clinical and aesthetic dermatology vol. 14,9 (2021): 33-40.
Spierings NMK. Evidence for the Efficacy of Over-the-counter Vitamin A Cosmetic Products in the Improvement of Facial Skin Aging: A Systematic Review. J Clin Aesthet Dermatol. 2021 Sep;14(9):33-40. PMID: 34980969; PMCID: PMC8675340.
Copy Download .nbib Format: NLM
Formulation and Evaluation of a Topical Niosomal Gel Containing a Combination of Benzoyl Peroxide and Tretinoin for Antiacne Activity [Retraction].

International journal of nanomedicine

[No authors listed]
PMID: 34168452
Int J Nanomedicine. 2021 Jun 18;16:4195. doi: 10.2147/IJN.S320896. eCollection 2021.

[This retracts the article DOI: 10.2147/IJN.S70449.].

Cite
Formulation and Evaluation of a Topical Niosomal Gel Containing a Combination of Benzoyl Peroxide and Tretinoin for Antiacne Activity [Retraction]. Int J Nanomedicine. 2021;16:4195doi: 10.2147/IJN.S320896.
(2021). Formulation and Evaluation of a Topical Niosomal Gel Containing a Combination of Benzoyl Peroxide and Tretinoin for Antiacne Activity [Retraction]. International journal of nanomedicine, 164195. https://doi.org/10.2147/IJN.S320896
"Formulation and Evaluation of a Topical Niosomal Gel Containing a Combination of Benzoyl Peroxide and Tretinoin for Antiacne Activity [Retraction]." International journal of nanomedicine vol. 16 (2021): 4195. doi: https://doi.org/10.2147/IJN.S320896
Formulation and Evaluation of a Topical Niosomal Gel Containing a Combination of Benzoyl Peroxide and Tretinoin for Antiacne Activity [Retraction]. Int J Nanomedicine. 2021 Jun 18;16:4195. doi: 10.2147/IJN.S320896. eCollection 2021. PMID: 34168452; PMCID: PMC8219221.
Copy Download .nbib Format: NLM
The efficacy and safety of topical Tretinoin combined with superficial X-ray therapy (SXRT) in treating periungual warts.

Dermatologic therapy

Xu J, Zhang D, Feng L, Liu Y, Diao Q.
PMID: 34967065
Dermatol Ther. 2021 Dec 29;e15295. doi: 10.1111/dth.15295. Epub 2021 Dec 29.

There are multiple treatment modalities for periungual warts (PWs), although most are destructive and painful, limiting their application. Radiotherapy is a non-invasive method suitable for treating PW patients with contraindications to invasive procedures. To investigate the efficacy and safety...

Cite
Xu J, Zhang D, Feng L, et al. The efficacy and safety of topical Tretinoin combined with superficial X-ray therapy (SXRT) in treating periungual warts. Dermatol Ther. 2021;e15295doi: 10.1111/dth.15295.
Xu, J., Zhang, D., Feng, L., Liu, Y., & Diao, Q. (2021). The efficacy and safety of topical Tretinoin combined with superficial X-ray therapy (SXRT) in treating periungual warts. Dermatologic therapy, e15295. https://doi.org/10.1111/dth.15295
Xu, Jinhui, et al. "The efficacy and safety of topical Tretinoin combined with superficial X-ray therapy (SXRT) in treating periungual warts." Dermatologic therapy vol. (2021): e15295. doi: https://doi.org/10.1111/dth.15295
Xu J, Zhang D, Feng L, Liu Y, Diao Q. The efficacy and safety of topical Tretinoin combined with superficial X-ray therapy (SXRT) in treating periungual warts. Dermatol Ther. 2021 Dec 29;e15295. doi: 10.1111/dth.15295. Epub 2021 Dec 29. PMID: 34967065.
Copy Download .nbib Format: NLM
Showing 169 to 178 of 178 entries